Functional genomics indicate that schizophrenia may be an adult vascular-ischemic disorder

Translational Psychiatry

Volumn 5, Issue 8, 2015, Pages

  Moises, H W ^a,b   Wollschlager D ^c   Binder, H ^c  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b Computational Genomics Lab ^*  (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; CREATINE PHOSPHATE; GLUTAMIC ACID; NITRIC OXIDE;

ADULT VASCULAR ISCHEMIA; ARTICLE; BRAIN ISCHEMIA; FUNCTIONAL GENOMICS; GENE EXPRESSION; GENETIC ASSOCIATION STUDY; HUMAN; LONG TERM POTENTIATION; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMISSION; SCHIZOPHRENIA; TIME; UPREGULATION; COMPLICATION; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SYNAPTIC TRANSMISSION;

BRAIN ISCHEMIA; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; LONG-TERM POTENTIATION; NEURONAL PLASTICITY; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION;

EID: 84990984091     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2015.103     Document Type: Article

References (96)

1. Rabinowitz J, Levine SZ, Haim R, Häfner H. The course of schizophrenia: Progressive deterioration, amelioration or both? Schizophr Res 2007; 91: 254-258.
2. Meyer-Lindenberg A, Bullmore ET. Functional brain imaging in schizophrenia. In: Weinberger DR, Harrison PJ (eds). Schizophrenia. Wiley-Blackwell: Chichester, UK, 2011; pp 353-366.
3. Olabi B, Ellison-Wright I, McIntosh AM, Wood SJ, Bullmore E, Lawrie SM. Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biol Psychiatry 2011; 70: 88-96.
4. Meyer-Lindenberg A. Neuroimaging and the question of neurodegeneration in schizophrenia. Prog Neurobiol 2011; 95: 514-516.
5. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 2003; 60: 1187-1192.
6. Owen MJ, O'Donovan MC, Gottesman II. Schizophrenia. In: McGuffin P, Owen MJ, Gottesman II (eds). Psychiatric Genetics and Genomics. Oxford University Press: Oxford, UK, 2002; pp 247-266.
7. Lichtenstein P, Yip BH, Björk C, Pawitan Y, Cannon TD, Sullivan PF et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: A population-based study. Lancet 2009; 373: 234-239.
8. van Os J, Kenis G, Rutten BP. The environment and schizophrenia. Nature 2010; 468: 203-212.
9. Moises HW, Yang L, Kristbjarnarson H, Wiese C, Byerley W, Macciardi F et al. An international two-stage genome-wide search for schizophrenia susceptibility genes. Nat Genet 1995; 11: 321-324.
10. Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database. Nat Genet 2008; 40: 827-834.
11. Welter D, MacArthur J, Morales J, Burdett T, Hall P, Junkins H et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res 2014; 42: D1001-D1006.
12. Sullivan PF. Puzzling over schizophrenia: Schizophrenia as a pathway disease. Nat Med 2012; 18: 210-211.
13. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 2008; 40: 1053-1055.
14. Riley B, Thiselton D, Maher BS, Bigdeli T, Wormley B, McMichael GO et al. Replication of association between schizophrenia and ZNF804A in the Irish Case- Control Study of Schizophrenia sample. Mol Psychiatry 2010; 15: 29-37.
15. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511: 421-427.
16. Ayalew M, Le-Niculescu H, Levey DF, Jain N, Changala B, Patel SD et al. Convergent functional genomics of schizophrenia: From comprehensive understanding to genetic risk prediction. Mol Psychiatry 2012; 17: 887-905.
17. Mistry M, Gillis J, Pavlidis P. Genome-wide expression profiling of schizophrenia using a large combined cohort. Mol Psychiatry 2013; 18: 215-225.
18. Cramer SC, Chopp M. Recovery recapitulates ontogeny. Trends Neurosci 2000; 23: 265-271.
19. Liu XS, Zhang ZG, Zhang RL, Gregg S, Morris DC, Wang Y et al. Stroke induces gene profile changes associated with neurogenesis and angiogenesis in adult subventricular zone progenitor cells. J Cereb Blood Flow Metab 2007; 27: 564-574.
20. Hudson CJ, Lin A, Cogan S, Cashman F, Warsh JJ. The niacin challenge test: Clinical manifestation of altered transmembrane signal transduction in schizophrenia? Biol Psychiatry 1997; 41: 507-513.
21. Chang SS, Liu CM, Lin SH, Hwu HG, Hwang TJ, Liu SK et al. Impaired flush response to niacin skin patch among schizophrenia patients and their nonpsychotic relatives: The effect of genetic loading. Schizophr Bull 2009; 35: 213-221.
22. Nave KA. Myelination and the trophic support of long axons. Nat Rev Neurosci 2010; 11: 275-283.
23. Drake CT, Iadecola C. The role of neuronal signaling in controlling cerebral blood flow. Brain Lang 2007; 102: 141-152.
24. Weber H, Klamer D, Freudenberg F, Kittel-Schneider S, Rivero O, Scholz CJ et al. The genetic contribution of the NO system at the glutamatergic post-synapse to schizophrenia: Further evidence and meta-analysis. Eur Neuropsychopharmacol 2014; 24: 65-85.
25. Cantor RM, Lange K, Sinsheimer JS. Prioritizing GWAS results: A review of statistical methods and recommendations for their application. Am J Hum Genet 2010; 86: 6-22.
26. Schmidt-Kastner R, van Os J, W M Steinbusch H, Schmitz C. Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia. Schizophr Res 2006; 84: 253-271.
27. R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2014 http: //www.R-project.org/.
28. Hamel E. Perivascular nerves and the regulation of cerebrovascular tone. J Appl Physiol 2006; 100: 1059-1064.
29. Zhang S, Boyd J, Delaney K, Murphy TH. Rapid reversible changes in dendritic spine structure in vivo gated by the degree of ischemia. J Neurosci 2005; 25: 5333-5338.
30. Di Filippo M, Tozzi A, Costa C, Belcastro V, Tantucci M, Picconi B et al. Plasticity and repair in the post-ischemic brain. Neuropharmacology 2008; 55: 353-362.
31. Heiss WD. Flow thresholds of functional and morphological damage of brain tissue. Stroke 1983; 14: 329-331.
32. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999; 399: 601-605.
33. González MI, Robinson MB. Neurotransmitter transporters: Why dance with so many partners? Curr Opin Pharmacol 2004; 4: 30-35.
34. Peltier J, O'Neill A, Schaffer DV. PI3K/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation. Dev Neurobiol 2007; 67: 1348-1361.
35. Horwood JM, Dufour F, Laroche S, Davis S. Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat. Eur J Neurosci 2006; 23: 3375-3384.
36. Schmidt-Kastner R, van Os J, Esquivel G, Steinbusch HW, Rutten BP. An environmental analysis of genes associated with schizophrenia: Hypoxia and vascular factors as interacting elements in the neurodevelopmental model. Mol Psychiatry 2012; 17: 1194-1205.
37. Zhao Z, Xu J, Chen J, Kim S, Reimers M, Bacanu SA et al. Transcriptome sequencing and genome-wide association analyses reveal lysosomal function and actin cytoskeleton remodeling in schizophrenia and bipolar disorder. Mol Psychiatry 2014; 20: 563-572.
38. Jia P, Wang L, Meltzer HY, Zhao Z. Common variants conferring risk of schizophrenia: A pathway analysis of GWAS data. Schizophr Res 2010; 122: 38-42.
39. Yu H, Bi W, Liu C, Zhao Y, Zhang D, Yue W. A hypothesis-driven pathway analysis reveals myelin-related pathways that contribute to the risk of schizophrenia and bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2014; 51: 140-145.
40. Sun J, Jia P, Fanous AH, van den Oord E, Chen X, Riley BP et al. Schizophrenia gene networks and pathways and their applications for novel candidate gene selection. PLoS One 2010; 5: E11351.
41. Pickard B. Progress in defining the biological causes of schizophrenia. Expert Rev Mol Med 2011; 13: E25.
42. Meynert T. Klinische Vorlesungen über Psychiatrie auf wissenschaftlichen Grundlagen. Braumüller: Wien, Austria, 1890.
43. Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR et al. White matter changes in schizophrenia: Evidence for myelin-related dysfunction. Arch Gen Psychiatry 2003; 60: 443-456.
44. Nave KA, Ehrenreich H. Myelination and oligodendrocyte functions in psychiatric diseases. JAMA Psychiatry 2014; 71: 582-584.
45. Lyons SA, Kettenmann H. Oligodendrocytes and microglia are selectively vulnerable to combined hypoxia and hypoglycemia injury in vitro. J Cereb Blood Flow Metab 1998; 18: 521-530.
46. Maurer I, Zierz S, Möller H-J. Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophr Res 2001; 48: 125-136.
47. Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 2002; 22: 2718-2729.
48. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL et al. Mitochondrial dysfunction in schizophrenia: Evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 2004; 9: 684-697, 643.
49. Altar CA, Jurata LW, Charles V, Lemire A, Liu P, Bukhman Y et al. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry 2005; 58: 85-96.
50. Falkai P, Parlapani E, Gruber O, Schmitt A. The neuropathology of schizophrenia: Central role for the hippocampus? In: Gattaz WF, Busatto G (eds). Advances in Schizophrenia Research 2009. Springer: New York, Dordrecht, Heidelberg, London, 2010; pp 149-165.
51. Harrison PJ, Lewis DA, Kleinman JE. Neuropathology of schizophrenia. In: Weinberger DR, Harrison PJ (eds). Schizophrenia. Wiley-Blackwell: Chichester, UK 2011; pp 372-392.
52. Cotton JM, Lewis NDC, Egenhofer AW. Vascular bed of the retina in mental disease. Arch Neurol Psychiatry 1940; 43: 891.
53. Senitz D, Winkelmann E. Neuronal structure abnormality in the orbito-frontal cortex of schizophrenics. J Hirnforsch 1991; 32: 149-158.
54. Kreczmanski P, Schmidt-Kastner R, Heinsen H, Steinbusch HW, Hof PR, Schmitz C. Stereological studies of capillary length density in the frontal cortex of schizophrenics. Acta Neuropathol 2005; 109: 510-518.
55. Kreczmanski P, Heinsen H, Mantua V, Woltersdorf F, Masson T, Ulfig N et al. Microvessel length density, total length, and length per neuron in five subcortical regions in schizophrenia. Acta Neuropathol 2009; 117: 409-421.
56. Meier MH, Shalev I, Moffitt TE, Kapur S, Keefe RS, Wong TY et al. Microvascular abnormality in schizophrenia as shown by retinal imaging. Am J Psychiatry 2013; 170: 1451-1459.
57. Uranova NA, Zimina IS, Vikhreva OV, Krukov NO, Rachmanova VI, Orlovskaya DD. Ultrastructural damage of capillaries in the neocortex in schizophrenia. World J Biol Psychiatry 2010; 11: 567-578.
58. Fels J, Jeggle P, Kusche-Vihrog K, Oberleithner H. Cortical actin nanodynamics determines nitric oxide release in vascular endothelium. PLoS One 2012; 7: E41520.
59. Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 2014; 506: 179-184.
60. Hanson DR. Gottesman II. Theories of schizophrenia: A genetic-inflammatoryvascular synthesis. BMC Med Genet 2005; 6: 7.
61. Reif A, Fritzen S, Finger M, Strobel A, Lauer M, Schmitt A et al. Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol Psychiatry 2006; 11: 514-522.
62. Lieberman JA. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry 1999; 46: 729-739.
63. Heiss WD. The ischemic penumbra: Correlates in imaging and implications for treatment of ischemic stroke. The Johann Jacob Wepfer award 2011. Cerebrovasc Dis 2011; 32: 307-320.
64. Harrison PJ. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999; 122: 593-624.
65. Huber G, Gross G, Schüttler R, Linz M. Longitudinal studies of schizophrenic patients. Schizophr Bull 1980; 6: 592-605.
66. Isohanni I, Järvelin MR, Jones P, Jokelainen J, Isohanni M. Can excellent school performance be a precursor of schizophrenia? A 28-year follow-up in the Northern Finland 1966 birth cohort. Acta Psychiatr Scand 1999; 100: 17-26.
67. Maccabe JH, Brébion G, Reichenberg A, Ganguly T, McKenna PJ, Murray RM et al. Superior intellectual ability in schizophrenia: Neuropsychological characteristics. Neuropsychology 2012; 26: 181-190.
68. Cernis E, Vassos E, Brébion G, McKenna PJ, Murray RM, David AS et al. Schizophrenia patients with high intelligence: A clinically distinct sub-type of schizophrenia? Eur Psychiatry 2015; 30: 628-632.
69. Ruhrmann S, Schultze-Lutter F, Maier W, Klosterkötter J. Pharmacological intervention in the initial prodromal phase of psychosis. Eur Psychiatry 2005; 20: 1-6.
70. Harrison PJ. Schizophrenia: A disorder of neurodevelopment? Curr Opin Neurobiol 1997; 7: 285-289.
71. Moises H, Zoega T, Li L, Hood L Genes and neurodevelopment in schizophrenia. In: DiLalla L(ed.). Behavior Genetics Principles-Principles in Development, Personality, and Psychopathology. American Psychological Association: Washington, DC, USA, 2004; pp 145-157.
72. Marenco S, Weinberger DR. The neurodevelopmental hypothesis of schizophrenia: Following a trail of evidence from cradle to grave. Dev Psychopathol 2000; 12: 501-527.
73. Weinberger DR, Levitt P. Neurodevelopmental origins of schizophrenia. In Weinberger DR, Harrison P (eds). Schizophrenia. Wiley-Blackwell: Chichester, UK, 2011; pp 393-412.
74. Barker DJ. Intrauterine programming of coronary heart disease and stroke. Acta Paediatr Suppl 1997; 423: 178-182, discussion 183.
75. Barker DJ, Eriksson JG, Forsén T, Osmond C. Fetal origins of adult disease: Strength of effects and biological basis. Int J Epidemiol 2002; 31: 1235-1239.
76. Barker DJ, Osmond C, Kajantie E, Eriksson JG. Growth and chronic disease: Findings in the Helsinki Birth Cohort. Ann Hum Biol 2009; 36: 445-458.
77. Andreasen NC. Beautiful Minds: An interview with John Nash and son by Dr. Nancy Andreasen for the Discovery Channel. In: Lahey, B. (ed.). Media Resources for Teaching Psychology CD-ROM/DVD. New York, NY, USA: McGraw-Hill Higher Education, 2003, ISBN 0072938854.
78. Klosterkötter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001; 58: 158-164.
79. Häfner H, An der Heiden W. Course and outcome. In: Mueser KT, Jeste DV (eds). Clinical Handbook of Schizophrenia. Guilford: New York, NY, USA, 2008; pp 100-113.
80. Sabri O, Erkwoh R, Schreckenberger M, Cremerius U, Schulz G, Dickmann C et al. Regional cerebral blood flow and negative/positive symptoms in 24 drug-naive schizophrenics. J Nucl Med 1997; 38: 181-188.
81. Potkin SG, Alva G, Fleming K, Anand R, Keator D, Carreon D et al. A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography. Am J Psychiatry 2002; 159: 227-237.
82. Suzuki M, Nohara S, Hagino H, Takahashi T, Kawasaki Y, Yamashita I et al. Prefrontal abnormalities in patients with simple schizophrenia: Structural and functional brain-imaging studies in five cases. Psychiatry Res 2005; 140: 157-171.
83. Rossini PM, Calautti C, Pauri F, Baron JC. Post-stroke plastic reorganisation in the adult brain. Lancet Neurol 2003; 2: 493-502.
84. Jardri R, Pouchet A, Pins D, Thomas P. Cortical activations during auditory verbal hallucinations in schizophrenia: A coordinate-based meta-analysis. Am J Psychiatry 2011; 168: 73-81.
85. Spence SA, Brooks DJ, Hirsch SR, Liddle PF, Meehan J, Grasby PM. A PET study of voluntary movement in schizophrenic patients experiencing passivity phenomena (delusions of alien control). Brain 1997; 120: 1997-2011.
86. Simons CJ, Tracy DK, Sanghera KK, O'Daly O, Gilleen J, Dominguez MD et al. Functional magnetic resonance imaging of inner speech in schizophrenia. Biol Psychiatry 2010; 67: 232-237.
87. Lips ES, Cornelisse LN, Toonen RF, Min JL, Hultman CM, Holmans PA et al. Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia. Mol Psychiatry 2012; 17: 996-1006.
88. Weinberger DR, Levitt P. Neurodevelopmental origins of schizophrenia. In: Weinberger DR, Harrison PJ (eds). Schizophrenia. Wiley-Blackwell: Oxford, UK, 2011; pp 393-412.
89. Widiger TA, Costa PT Jr. Personality and personality disorders. J Abnorm Psychol 1994; 103: 78-91.
90. Häfner H, Maurer K, Trendler G, an der Heiden W, Schmidt M. The early course of schizophrenia and depression. Eur Arch Psychiatry Clin Neurosci 2005; 255: 167-173.
91. Deckersbach T, Miller KK, Klibanski A, Fischman A, Dougherty DD, Blais MA et al. Regional cerebral brain metabolism correlates of neuroticism and extraversion. Depress Anxiety 2006; 23: 133-138.
92. Gur RC, Gur RE, Resnick SM, Skolnick BE, Alavi A, Reivich M. The effect of anxiety on cortical cerebral blood flow and metabolism. J Cereb Blood Flow Metab 1987; 7: 173-177.
93. Ito H, Kawashima R, Awata S, Ono S, Sato K, Goto R et al. Hypoperfusion in the limbic system and prefrontal cortex in depression: SPECT with anatomic standardization technique. J Nucl Med 1996; 37: 410-414.
94. Licinio J. Translational psychiatry: Leading the transition from the cesspool of devastation to a place where the grass is really greener. Transl Psychiatry 2011; 1: E1.
95. Thagard PR. The best explanation: Criteria for theory choice. J Philosophy 1978; 75: 76-92.
96. Camici PG, d'Amati G, Rimoldi O. Coronary microvascular dysfunction: Mechanisms and functional assessment. Nat Rev Cardiol 2015; 12: 48-62.